Review Article
Ferulated Arabinoxylans and Their Gels: Functional Properties and Potential Application as Antioxidant and Anticancer Agent
Table 1
Origin, FA content, and current/potential application of AX in biomedical and pharmaceutical fields.
| AX origin | FA content (μg/mg AX) | Currently/potential application in biomedical/pharmaceutical field | Reference |
| Nejayote/maize bran | 0.012/0.025 | Entrapment of probiotic | [32] | Nejayote/maize bran | 0.012/0.025 | Entrapment and controlled release of insulin and probiotics targeted to colon | [11] | Maize bran | 0.34 | Controlled release of insulin and β-lactoglobulin | [33] | Maize bran | 0.25 | Controlled release of insulin targeted to colon | [34] | Maize bran | 4.0 | Entrapment and controlled release of methyl xanthine | [35] | Wheat endosperm | 2.3 | Controlled release of proteins | [36] | Wheat endosperm | 0.53 | Entrapment of probiotics | [37] | Wheat bran | 0.435 | Antitumor and immunomodulatory activity | [16, 38] | Wheat bran | — | Prebiotic | [39] | Rice bran | — | Antitumor and immunomodulatory activity | [40] | Rice bran (MGN-3/Biobran) | — | Cancer immunotherapy Prevention and inhibition of cancer Synergistic effect with chemotherapeutic agents | [15, 41, 42] | Finger millet bran | 0.001 | Immunomodulatory activity | [29] | Ispaghula (Plantago ovata) seed | nd | Drug carrier | [31, 43] | Ispaghula (Plantago ovata) seed | — | Controlled release of mucoadhesive oral films | [44, 45] |
|
|
nd: no detectable; −: no reported.
|